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ABSTRACT 
Objective: To conduct a systematic review and meta-analysis of the evidence on the effects 
of β-alanine supplementation on exercise capacity and performance.  
Design: This study was designed in accordance with PRISMA guidelines. A three level 
mixed effects model was employed to model effect sizes and account for dependencies within 
data. 
Data sources: Three databases (PubMed, Google Scholar, Web of Science) were searched 
using a number of terms (“β-alanine” and “beta-alanine” combined with “supplementation”, 
“exercise”, “training”, “athlete”, “performance”, and “carnosine”).  
Eligibility criteria for selecting studies: Inclusion/exclusion criteria limited articles to 
double-blinded, placebo-controlled studies investigating the effects of β-alanine 
supplementation on an exercise measure. All healthy participant populations were considered, 
whilst supplementation protocols were restricted to chronic ingestion. Crossover designs 
were excluded due to the long washout period for skeletal muscle carnosine following 
supplementation. A single outcome measure was extracted for each exercise protocol and 
converted to effect sizes for meta-analyses.  
Results: Forty individual studies employing 65 different exercise protocols and totalling 70 
exercise measures in 1461 participants were included in the analyses. A significant overall 
effect size of 0.18 (95%CI: 0.08, 0.28) was shown. Meta-regression demonstrated that 
exercise duration significantly (P=0.004) moderated effect sizes. Subgroup analyses also 
identified the type of exercise as a significant (P=0.013) moderator of effect sizes within an 
exercise timeframe of 0.5-10 min with greater effect sizes for exercise capacity [0.4998 
(95%CI: 0.246, 0.753)] vs. performance [0.1078 (95%CI: -0.201, 0.416)]. There was no 
moderating effect of training status (P=0.559), intermittent or continuous exercise (P=0.436) 
or total amount of β-alanine ingested (P=0.438). Co-supplementation with sodium 
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bicarbonate resulted in the largest effect size when compared to placebo [0.43 (95%CI: 0.22, 
0.64)]. Summary/Conclusions: β-alanine had a significant overall effect while sub-group 
analyses revealed a number of modifying factors. These data allow individuals to make 
informed decisions as to the likelihood of an ergogenic effect with β-alanine supplementation 
based upon their chosen exercise modality. 
 
Key points: 
 Carnosine (β-alanyl-L-histidine) is abundant in skeletal muscle suggesting it plays an 
important role during exercise, with a key physiological role considered to be 
intracellular pH regulation; 
 β-alanine supplementation can increase muscle carnosine concentration and improve 
exercise capacity and performance; 
 There may be a number of confounding factors, including exercise type, duration and 
mode and population, that may influence the effects of β-alanine supplementation; 
Novel findings from the current study:  
 There was an overall ergogenic effect of β-alanine supplementation on exercise; 
 Exercise duration was the greatest factor influencing effect sizes: a duration of 0.5 to 
10 min results in the greatest gains while very short duration exercise (<0.5 min) 
clearly results in no benefits; 
 Effect sizes for exercise capacity were larger than for performance, particularly during 
exercise lasting from 0.5 to 10 min in duration; 
 The effect of β-alanine on trained individuals showed smaller effect sizes than non-
trained individuals, while isolated limb and whole body exercise were shown to 
equally benefit from β-alanine; 
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 Co-supplementation of β-alanine and sodium bicarbonate, to increase both 
intracellular and extracellular buffering capacity, was shown to result in additional 
improvements above β-alanine alone. 
 
Keywords: Beta-alanine supplementation; muscle carnosine; exercise capacity; exercise 
performance; acidosis; buffering capacity; sodium bicarbonate; co-supplementation 
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Introduction 
The purported pleiotropic effects of carnosine (β-alanyl-L-histidine) have attracted interest in 
this histidine-containing dipeptide in recent years due to its potential ergogenic and 
therapeutic benefits.[1] Its abundance in skeletal muscle suggests it plays an important role 
during exercise, with a key physiological role considered to be intracellular acid-base 
regulation, although further roles for carnosine have also been suggested, such as protection 
against oxidative damage, glycation and regulation of calcium sensitivity (for review, see 
[2]). The rate limiting factor to muscle carnosine synthesis is the availability of β-alanine 
from the diet,[3] with supplementation shown to increase skeletal muscle concentrations in 
both upper and lower limbs.[3-9] This has led to investigations into the effects of β-alanine 
supplementation, and thus increased muscle carnosine concentration, on capacity and 
performance within a variety of exercise tests and sample populations.  
 
A previous meta-analysis [10] showed the efficacy of β-alanine supplementation on exercise 
with a significant effect on capacity but not performance tests; although the authors 
acknowledged that this might have been due to the lack of studies employing a performance 
measure at the time. The exercise timeframe in which β-alanine was most effective was 1 to 4 
min, with no effect on exercise of less than 1 min in duration. Although a positive effect was 
shown on exercise of more than 4 min in duration, there was a lack of protocols employing 
long-duration continuous exercise; the majority of the longer duration exercise studies 
employed incremental protocols of such low intensity during the initial stages that they were 
unlikely to produce any significant changes that result in fatigue. Therefore, the duration of 
such tests is somewhat deceiving since it is only the latter stages that may be susceptible to 
changes in muscle carnosine with supplementation. Furthermore, in line with the primary 
suggested role of muscle carnosine, a 0.5 to 10 min timeframe may be more appropriate since 
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acidosis following 20 s of exercise may already contribute to fatigue,[11] while exercise of 7-
8 min in duration has been shown to have a high contribution from glycolytic energy 
sources.[12] Thus, determination of the effect of β-alanine within these different exercise 
durations would further contribute to the evidence base as to the main physiological role of 
carnosine in skeletal muscle during exercise.  
 
It would be of interest to investigate the ability of β-alanine to improve exercise measures in 
different sample populations (i.e., trained and non-trained) and exercise modes (i.e., whole 
body and isolated limb exercise) since its efficacy for trained individuals [13 14] and whole 
body exercise has been questioned.[15] Furthermore, since over half of professional 
footballers reported taking β-alanine,[16] determination of its effect on intermittent, as well 
as continuous, exercise is warranted. Additionally, since muscle carnosine increases are dose-
dependent,[17] it appears reasonable to suggest that the total amount ingested or 
supplementation duration may influence any exercise gains. Co-supplementation of β-alanine 
with sodium bicarbonate may lead to additive gains via increased intracellular (from 
increased muscle carnosine concentrations) and extracellular (from increased blood 
bicarbonate concentrations) buffering capacity.[18] Therefore, it would be of interest to 
determine the effect of co-supplementation of β-alanine with sodium bicarbonate to 
determine whether any improvements are additive and exceed those with β-alanine alone.  
 
The aim of this study was to perform a systematic review and meta-analysis on the effects of 
β-alanine supplementation, accounting for a number of potential modifying factors including 
exercise duration, type and mode, sample population, total dose employed and study length. 
Furthermore, the combined effects of sodium bicarbonate and β-alanine were also 
investigated.  
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Methods 
Study Eligibility:  
The protocol for this study was designed in accordance with PRISMA guidelines,[19] and the 
question determined in respect of PICO (Population, Intervention, Comparator and 
Outcomes). The population included healthy human males and females of any age. 
Recreationally active and professional athletes were considered for inclusion. Studies 
conducted with diseased-state participants were excluded. The intervention must have 
employed a chronic (>1 day) β-alanine supplementation protocol. Since the net retention of 
β-alanine used for muscle carnosine synthesis over 4 weeks of supplementation is 6.0 – 6.5% 
over the dose range 3.2 to 6.4 g∙day-1 (estimated from [3 20]), acute supplementation 
protocols were not included since a single dose of β-alanine would not result in any 
meaningful increases in muscle carnosine. No cross-over designs were included in the 
analyses if they did not demonstrate a complete washout of muscle carnosine, given the long 
washout period for muscle carnosine (up to 16 weeks) following doses of between 1.6 and 
4.8 g·day
-1
 of β-alanine.[6 17] Although Danaher, et al. [21] reported no significant 
differences in muscle carnosine concentration following 12 weeks of washout, a lack of a 
statistical significance does not exclude the possibility that carnosine remained elevated in 
some individuals. Thus, following a discussion and agreement between all reviewers, this 
study was not included in any of the analyses. In relation to the comparator, the protocol for 
this study determined that only double-blinded, placebo-controlled studies were included. 
Studies that reported on outcomes based on exercise performance and capacity were 
considered for inclusion. For the purpose of this review, exercise capacity tests were defined 
as those requiring exertion to the point of volitional fatigue, whilst performance based tests 
were defined as those requiring pacing strategies that may not necessarily elicit maximal 
exertion. Only peer-reviewed, original human studies published between 2002 and February 
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2016 were included within this review. We applied a date restriction of 2002 to coincide with 
the publication of the first paper to investigate the association between muscle carnosine and 
exercise.[22] Where data were incomplete, authors were contacted to obtain the relevant 
information. Data from one study was not received,[23] meaning that this study was not 
included in the analyses. 
 
Search Strategy and Quality Assessment: 
An electronic search of the literature was undertaken by BS using three databases (PubMed, 
Google Scholar and Web of Science) to identify all relevant articles. The search terms “β-
alanine” and “beta-alanine” were individually concatenated with “supplementation”, 
“exercise”, “training”, “athlete”, “performance”, and “carnosine”; search terms were 
restricted to the title of the articles. Following the removal of duplicates, a 2-phase search 
strategy was subsequently employed by three independent reviewers (BS, GGA and KES). 
Phase one assessed the eligibility of the title and abstract of every hit generated from the 
search terms against the inclusion/exclusion criteria. Studies that had questionable suitability 
were included at this stage and the final decision was reached at the next phase (phase two). 
In phase two, full articles were retrieved and assessed against the eligibility criteria. 
Reference lists of relevant original and review articles were screened to ensure all relevant 
studies were included. Any differences of opinion relating to study eligibility were resolved 
through discussion. The search strategy is summarised in Figure 1. The final search was 
completed in February 2016.  
 
A funnel plot (Supplementary Figure 1) was used to visually determine publication bias; BS 
and BG performed this according to standard recommendations.[24] Some data appeared to 
contribute to some asymmetry in the plot, with one study having a very low sample size (BA 
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= 5, PL = 2;[25]). High standard errors shown for the other two [26 27] are likely due to high 
inter-individual responses within the respective studies. It was concluded that there was no 
publication bias and inclusion of all study estimates was warranted. BS and KES 
independently reviewed the strength of the evidence provided by all studies using the criteria 
outlined in the Consolidated Standards of reporting Trials (CONSORT statement;[28 29] 
Supplementary Table 1). Any differences between reviewers were resolved by discussion 
until an agreement was reached. Items 3b, 6b, 7b, 14a, 14b, 17b, 18, 23 and 24 were 
removed, as they were not applicable to any of the studies. The results of the CONSORT 
assessment were not used to exclude any study that did not meet the standards or 
requirements but provide an objective measure of each study’s adherence to the minimum set 
of recommendations for reporting randomised trials as determined by CONSORT. 
 
Data Extraction and Variable Categorisation:  
Data extraction was conducted by BS using a standardised and pre-piloted data extraction 
form. A number of protocols resulted in several outcome measures of the same exercise test; 
in order to avoid duplication bias, only a solitary outcome measure from each exercise 
protocol was included. Thus, where a single exercise protocol resulted in one or more 
outcome measures, the outcome measure included was based upon a hierarchy agreed upon 
by all reviewers to ensure consistency in data extraction. Data were extracted according to 
availability, prioritising exercise measures over physiological measures, according to the 
following hierarchical profile: 
1. Total work done 
2. Mean output throughout the test (i.e., mean power output; mean velocity; mean 
height) 
3. Time to completion (performance test)/time to exhaustion (capacity test) 
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4. Oxygen consumption (i.e., VO2max or VO2peak) 
Where multiple time points following supplementation existed (i.e., 0 - 4 and 0 - 10 weeks), 
post-supplementation outcome data were extracted from the final time point available. This 
was performed to ensure the highest possible accumulation of muscle carnosine due to β-
alanine supplementation and thus, theoretically, the most likely time point to show any effect.  
 
Following extraction, data were allocated into categories to allow for sub-group analyses. 
This included separating data by exercise duration according to the approach of Hobson et 
al.[10] [duration 1], namely 0 to 1 min, 1 to 4 min and in excess of 4 min, which were chosen 
to consider the proposed physiological mechanisms of carnosine, in particular pH buffering. 
Additional sub-group analyses were performed according to exercise duration using the 
following categories [duration 2]: 0-0.5 min; 0.5-10 min; 10 min+. The lower limit was 
chosen since Bogdanis et al.[11] suggested that sprint performance may be affected by the 
acidosis that occurred during the initial 20 s of exercise. Although maximal H
+
 accumulation 
in blood occurs after approximately 4 min,[30] total anaerobic energy contribution during 4 
km cycling time-trial (lasting ~6 min) is ~25%,[31] while Stellingwerff et al.[12] showed 
non-oxidative glycolysis contributes approximately 12% towards total energy contribution 
during 2000 m rowing (lasting in excess of 7 min). Thus, to ensure inclusion of all exercise 
with a substantial contribution from anaerobic energy sources, an upper limit of 10 min was 
determined. All exercise in excess of 10 min, with a likely predominantly aerobic energy 
contribution, made up the final category.  
 
Exercise protocols were categorised according to whether they measured exercise capacity or 
performance [exercise type]. Capacity tests require exertion to the point of volitional 
exhaustion, resulting in a maximal production of H
+
, whereas performance tests rely more 
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upon pacing strategies that might not elicit maximal exertion.[32] Analyses also separated 
investigations according to the sample populations recruited to the study [training status], 
since it has been suggested that trained individuals may be less responsive to β-alanine 
supplementation.[13 14] Studies were categorised as using trained individuals if the sample 
population was engaged in a structured training programme and whose training plan was 
relevant for the exercise task employed to study the effects of β-alanine; those individuals 
who did not fit this description (i.e., recreationally active; non-trained) were categorised as 
non-trained. Exercise tests were additionally categorised according to whole-body or isolated 
limb exercise [exercise mode], since differences in exercise mode influence energy substrate 
utilisation [33] and oxygen uptake kinetics.[34] Differences in whole-body and isolated 
muscle recruitment have also been suggested to contribute to the efficacy of β-alanine due to 
differences in whole body versus local muscle acidosis.[15] Exercise tests were similarly 
categorised according to whether they employed an intermittent or continuous exercise 
protocol [intermittent]. Since increases in muscle carnosine appear to be dose dependent,[17] 
we analysed the effect of total dose [total amount] and study length [study length] as 
continuous variables (in grams and days). Further sub-analysis was performed on studies that 
investigated the effect of co-supplementation of β-alanine and sodium bicarbonate on 
exercise [co-supplementation].  
 
Data Analysis  
Data were converted to observed effect sizes and their variances  calculated 
according to Morris [35]: 
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Where  refers to the BA group and  refers to PL.  is the pooled standard deviation 
and defined as: 
 
 is a bias correction and equal to:  
 
The effect size variance  was calculated as 
 
 
To calculate the observed effect size variance, the correlation between pre- and post-
supplementation outcomes ( ) was required. A single correlation value was estimated 
for all observed effect sizes. Raw data were obtained for 9 of the 40 included studies, 
comprising a total of 12 outcomes. The average pre- to post-supplementation correlation 
value obtained was 0.877  0.20; a weighted average pre- to post-supplementation 
correlation value of 0.95 (0.88, 0.97) was obtained. Therefore, a single pre- to post-
supplementation correlation value of 0.9 was used to calculate . Sensitivity analyses were 
also carried out using a single pre- to post-supplementation correlation value of 0.7. 
 
A three level mixed effects model was used to model effect sizes and account for 
dependencies within the data. The basic model consisted of three regression equations, one 
for each level [36]: 
 with   (level 1: sample) 
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The equation at the first level states that  the -th observed effect size from study  is 
equal to the corresponding population value  plus a random deviation,  that is normally 
distributed with mean zero and variance obtained as described above. The second level 
equation represents the outcome level and states that the population effects for the different 
outcomes within a study can be decomposed into a study mean ( ) and random residuals 
. 
 with   (level 2: outcome) 
The third level is an extension of the common random effects model and states that mean 
study effects  can vary around an overall mean  with the random variation : 
 with     (level 3: study) 
The between study variance in the mean effect, , reflects the covariance between two effect 
sizes from the same study. Van den Noortgate, et al. [36] previously demonstrated that the 
three-level model can provide appropriate mean effect size estimates and standard error 
estimates across a variety of realistic situations. The model was then extended by 
incorporating fixed effects in an attempt to further explain the variation in observed effects 
sizes. The fixed effects assessed included characteristics of the outcomes ([exercise 
duration], [exercise type], [training status], [exercise mode]) and studies ([total dose], [study 
length]). Subgroup analyses performed on outcomes from studies providing a co-
supplementation group comprising β-alanine and sodium bicarbonate were performed using a 
two-level meta-analysis due to limited nesting of outcomes within studies. Additionally, 
effect sizes were computed comparing the co-supplementation group (BASB) relative to the 
placebo group (PL) and the co-supplementation group relative to the β-alanine only (BA) 
group. All data were analysed using the rma and rma.mv functions in the metafor package 
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[37] in R (R Foundation for Statistical Computing, Vienna Austria) and significance level 
was previously set at P < 0.05. 
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Results 
Included Study Characteristics  
Forty published studies met the criteria for inclusion in the analyses (Table 1). A total of 65 
exercise tests were employed across the various studies resulting in 70 exercise outcome 
measures in 1461 participants (BA: N = 746; PL: N = 715). Grouping of studies and exercise 
protocols for the various sub-analyses performed is presented in Table 2.   
 
Meta-analysis 
Overall 
Results from the meta-analysis showed a small significant mean effect size of 0.180 (95%CI: 
0.078, 0.284). Substantial heterogeneity was noted with systematic variance (level 2 and level 
3 variance) accounting for ~72% of the total variance (Table 3). Sensitivity analysis using a 
pre- to post-supplementation correlation of 0.7 resulted in a small main effect estimate of 
0.180 (95%CI: 0.076, 0.292) with a concomitant increase in sampling variance that resulted 
in systematic variance accounting for ~36% of the total variance.  
 
Univariate Meta-regressions 
There was a significant moderating effect of [duration 1] (P = 0.003) with results showing 
small significant effect sizes for durations of 1-4 min [0.210 (95%CI: 0.057, 0.362) and 4+ 
min [0.233 (95%CI: 0.059, 0.407), but not 0-1 min [0.016 (95%CI: -0.223, 0.254). Similarly, 
there was a significant moderating effect of [duration 2] (P = 0.004, Figure 2) with results 
showing a small significant effect size for durations of 0.5-10 min [0.224 (95%CI: 0.088, 
0.361). There was a tendency towards significance for 10+ min [0.174 (95%CI: -0.030, 
0.377) but effect size was not significant for 0-0.5 min [0.040 (95%CI: -0.220, 0.300).  
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There was no moderation effect distinguishing between the different levels of [exercise type] 
(P = 0.256), [training status] (P = 0.559), [exercise mode] (P = 0.931) and [intermittent] (P = 
0.436). Similarly, no moderation effect was obtained for the continuous variable [total 
amount] (P = 0.438) on effect sizes. However, there was a moderation effect of [study length] 
(P = 0.005) with an apparent 0.011 increase in effect size each day beyond 20 days of 
supplementation (Table 3). However, this result appeared to be driven by the presence of two 
outliers (Cook's distance 1.8 and 0.7), and when a sensitivity analysis was performed without 
these data points, [study length] no longer had a significant effect (P = 0.685).  
 
Further analyses 
Due to the strong effect of [duration 2] on effect sizes, further meta-regressions were 
performed using [duration 2]. Sub group analyses were completed for the outcomes within 
0.5-10 min (N = 41) only. No moderation effects were shown for [total amount] (P = 0.831), 
[study length] (P = 0.309), and the different levels of [exercise mode] (P = 0.507), 
[intermittent] (P = 0.255) or [training status] (P = 0.874). However, there was a significant 
moderation effect distinguishing between the two levels of [exercise type] (P = 0.01) with 
higher effect sizes for exercise capacity than performance [0.4998, medium effect (95%CI: 
0.246, 0.753) vs. 0.1078, small effect (95%CI: -0.201, 0.416). 
 
Analysis of [co-supplementation] showed that, in comparison to PL, BASB resulted in a 
significant effect size of 0.433 (0.230, 0.637; P < 0.001). Furthermore, compared to BA, 
BASB also resulted in a significant effect size of 0.242 (0.071, 0.412; P = 0.006; Figure 3).   
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Discussion 
The results of this meta-analysis showed a significant positive overall effect of β-alanine 
supplementation on exercise, supporting the efficacy of increased muscle carnosine to 
improve exercise. Exercise duration was the greatest influencing factor regarding the efficacy 
of β-alanine supplementation. Replicating the duration timeframes of Hobson, et al. [10] 
yielded similar results; significant effect sizes were shown for exercise 1 to 4 min in duration, 
supporting previous evidence that β-alanine is beneficial for this exercise timeframe. No 
effect was shown for exercise protocols lasting less than 1 min, and considering a mechanism 
of action relating to increased intracellular buffering, this would make sense given that this 
duration of exercise is unlikely to be limited by intracellular H
+
 accumulation.[38] This 
finding also provides some indirect evidence in opposition to the influence of increased 
muscle carnosine content on calcium sensitivity of the contractile apparatus or calcium 
release from the sarcoplasmic reticulum. This is in agreement with the recent data of Hannah, 
et al. [39] who showed no effect of β-alanine on maximal explosive voluntary contractions 
suggesting that calcium sensitivity and release might not be the primary mechanisms by 
which increased carnosine improves whole muscle exercise in humans. Exercise of longer 
than 4 min in duration was improved with β-alanine supplementation, with greater effect 
sizes than exercise 1-4 min in duration (0.233 vs. 0.210), though we speculate that this may 
be due to shorter duration protocols (6-7 min,[7 40]), which may be more susceptible to 
increases in muscle carnosine if its primary mechanism is considered to be that of pH 
buffering, being grouped with those of longer duration (30-60 min,[41 42]). 
 
Although results reported within the current study agree somewhat with the categorisation of 
exercise durations employed by Hobson, et al. [10], we further explored the effect of exercise 
duration using adapted criteria. Short duration exercise (≤0.5 min) was not benefited from 
18 
 
supplementation (d = 0.040), while effect sizes for moderate duration exercise (0.5-10 min) 
were significant (d = 0.224). However, β-alanine was no longer shown to be effective for 
longer duration exercise (>10 min), although there was still a moderate effect size (d = 
0.174). It was supposed that these data may have been influenced by incremental protocols 
with a low intensity during the initial stages that were unlikely to induce fatigue. Therefore, 
the duration of such tests is somewhat deceiving since it is only the latter stages, conducted at 
higher exercise intensities, that may be susceptible to changes in muscle carnosine content. 
Although individual studies appear to confirm this hypothesis, there were no differences in 
effect sizes between continuous and incremental protocols (data not shown). Nonetheless, 
here we provide novel evidence to suggest that exercise of 0.5 to 10 min in duration to be the 
exercise timeframe in which β-alanine supplementation is most influential. 
 
Exercise capacity and performance were both improved by supplementation, although effect 
sizes suggested β-alanine to be almost twice as effective at improving exercise capacity. 
Further meta-regressions were performed on outcomes within 0.5-10 min due to the strong 
effect of duration on effect sizes, and showed higher effect sizes for exercise capacity than 
performance indicating that exercise capacity tests within this timeframe will likely elicit the 
greatest improvements with β-alanine supplementation. It has previously been suggested that 
performance tests, such as time-trials, may be influenced by intrinsic pacing,[32] potentially 
making them less likely to be influenced by increased muscle carnosine concentration. The 
majority of capacity tests included in the analyses were performed until exhaustion, likely 
resulting in a maximal production of H
+
, and thus are sensitive to changes in buffering 
capacity. As such, current data suggest that exercise capacity tests provide greater scope to 
identify significant effects of β-alanine supplementation, particularly within a 0.5 to 10 min 
timeframe.  
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There has been doubt raised as to the efficacy of β-alanine in well-trained participants,[13 
14], perhaps due to adaptions to training such as increased buffering capacity, which may 
minimise the contribution of increased muscle carnosine content in these individuals. The 
findings of the current study showed significant effect sizes for non-trained individuals only, 
suggesting they may be more susceptible to exercise improvements than their well-trained 
counterparts. This appears in contrast to Painelli, et al. [43], who directly compared the 
efficacy of β-alanine supplementation on training status using a trained and non-trained 
population and showed it to be equally effective in both sets of participants. Nonetheless, 
there were no differences in effect sizes between trained and non-trained populations in this 
study, while effect sizes for the trained group were close to the overall effect of β-alanine 
(0.144 vs. 0.180). Although it appears trained athletes might experience smaller gains, such 
changes may translate into worthwhile improvements in an applied setting (i.e., competition). 
Thus, this meta-analysis provides some evidence to support the efficacy of β-alanine in non-
trained and trained populations, though improvements are likely to be greater in non-trained 
individuals.  
 
The efficacy of β-alanine may be influenced by the mode of exercise performed, specifically 
whole-body versus isolated limb activity. Smaller muscle groups, such as upper-body 
muscles, may be more subjected to local acidosis than whole body exercise.[44] In addition, 
increased muscle tension imposed by the type of muscle contraction can mechanically reduce 
peripheral blood flow and oxygen extraction,[45] which may lead to an increased muscle 
acidosis. Therefore, it has been suggested that differences in muscle recruitment between 
activities such as cycling and running may lead to discrepancies in the apparent efficacy of 
the supplement.[15] The current data suggest, however, that the efficacy of β-alanine is not 
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affected by the mode of exercise and that both isolated limb and whole-body exercise are 
equally likely to benefit. Indeed, individual studies do provide evidence that whole-body type 
tasks can be improved by β-alanine supplementation.[40 46 47] Nonetheless, well-controlled 
experiments specifically designed to address whether there is a greater effect of local versus 
whole body acidosis are warranted. Additionally, intermittent and continuous protocols were 
both equally improved with β-alanine. However, most intermittent tests were not sport-
specific protocols and thus, further research investigating the effect of β-alanine within 
applied sport-specific settings is warranted. 
 
Neither the total amount ingested, nor supplementation duration, mediated the effect of β-
alanine supplementation on exercise outcomes. These results may be due to the wide range of 
dosing strategies employed, meaning individuals performed exercise at various stages of 
increased muscle carnosine content. Although Stellingwerff et al. [17] showed that increases 
in muscle carnosine concentration were dependent on the total amount of β-alanine 
consumed, their study employed two low doses (1.6 and 3.2 g∙day-1), whereas most studies 
included in this meta-analysis employed higher doses. The time course of carnosine 
accumulation with doses in excess of 3.2 g∙day-1 is yet to be determined and given that most 
studies did not directly measure muscle carnosine content, it is not possible to determine 
whether individuals performed exercise following similar increases in muscle carnosine, 
although this would seem unlikely. This meta-analysis showed that the total amount of β-
alanine ingested does not directly influence its efficacy, making it difficult to make specific 
recommendations as to the optimal dosing strategy for individuals. Nonetheless, 
supplementation of 1.6 g·day
-1
 for as little as two weeks has been shown to increase muscle 
carnosine,[17] while improvements in exercise have been shown at doses ranging from 3.2 – 
6.4 g·day
-1
 for 4 – 12 weeks.[4 26] Further research should determine the required dosing 
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strategy to attain maximal carnosine accumulation in muscle and whether maximal exercise 
improvements occur at an identical time point. 
 
It has been suggested that co-supplementation of β-alanine with sodium bicarbonate may 
result in further exercise gains over β-alanine alone, due to an increase in both intracellular 
and extracellular buffering capacity. Six of the nine studies encountered in our search strategy 
investigating co-supplementation were included in the analysis. The majority of studies that 
employed acute doses of sodium bicarbonate have shown co-supplementation to result in 
non-significant effects on performance.[13 18 47] The only study that employed a chronic (7 
d) sodium bicarbonate supplementation phase showed a significant effect of the additional 
sodium bicarbonate supplementation with β-alanine over β-alanine alone.[48]  This may be 
due to the multiple-bout nature of the test, which likely resulted in a higher acidosis than the 
continuous exercise protocols employed in other studies;[30 49] or due to the chronic 
supplementation protocol employed, which may have resulted in a more pronounced blood 
alkalosis,[50] although the authors did not measure this directly. Nonetheless, the current 
meta-analytic data suggest that co-supplementation of β-alanine with sodium bicarbonate can 
lead to additional gains over those with β-alanine alone. The reason for the apparent disparity 
between our findings and the individual study results may be due to the statistical power of 
the studies undertaken. Studies investigating the effects of combined supplementation have 
used relatively small samples sizes, which may have hindered standard analytical approaches, 
with many of these studies also including a magnitude based inferences approach,[51] 
showing small but meaningful additional improvements with co-supplementation.[18 40] 
Taken together, these data suggest that the co-supplementation of β-alanine with sodium 
bicarbonate results in further benefits than supplementation with β-alanine alone. 
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Nonetheless, further investigation is required since the current data are based upon the results 
of six individual studies only.  
 
This study is not without its limitations. All outcome measures were converted to effect sizes 
to standardise the data and subsequently perform our meta-analyses. It has previously been 
suggested that converting data to mean power may be more appropriate so that meta-analysed 
performance effects could be applied directly to athletic performance and practical 
recommendations for coaches and athletes.[52] However, the sheer variety of exercise 
protocols included in this analysis meant that it was not possible to convert all available data 
into power output. Furthermore, we feel that our analytical approach provides a 
comprehensive and clear analysis of the data, clarifying its significance to different athletic 
populations. Although our choice of sub-analyses and categorisation of exercise tests 
revealed insightful information on ergogenic properties of β-alanine supplementation, we 
acknowledge that alternative sub-analyses could have been performed and that our definitions 
to categorise studies into these sub-analyses may differ from other authors. However, we 
believe our choices to be relevant from a practical standpoint (i.e., in a sport context) and we 
have attempted to support this with an evidence base. 
 
In conclusion, β-alanine supplementation had a significant overall ergogenic effect on 
exercise. Exercise duration was the greatest influencing factor on the efficacy of β-alanine 
supplementation, with a timeframe of 0.5 to 10 min likely to result in the greatest gains, while 
very short duration exercise clearly results in no benefits. Exercise capacity resulted in 
greater effect sizes than exercise performance; this was particularly apparent for exercise 
lasting 0.5 to 10 min. The efficacy of β-alanine for non-trained individuals was clearly 
demonstrated, while lower effect sizes were shown for trained populations, though these may 
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still translate into competitive gains. Isolated limb versus whole body exercise benefitted 
equally from β-alanine supplementation. The co-supplementation of β-alanine and sodium 
bicarbonate resulted in the largest effect sizes and also resulted in greater gains than β-alanine 
alone.  
 
From a practical standpoint, these data allow individuals to make informed decisions as to the 
likelihood of an ergogenic effect with β-alanine supplementation based upon their chosen 
exercise modality (e.g. 400, 800 and 1500 m running; 4 km cycling; 100, 200 and 400 m 
swimming) and coaches can support claims as to the efficacy of this supplement to their 
athletes. Athletic individuals can also save time and resources if they are unlikely to obtain 
any exercise gains due to their preferred sport (e.g. 100 m running; 25 m swimming; >30 min 
cycling), although improvements with supplementation during training should not be 
dismissed since this will likely incorporate repeated exercise bouts and activity of longer 
duration than competition. Individuals are advised to supplement daily with β-alanine for a 
minimum of 2 – 4 weeks at a dose of 3.2 – 6.4 g·day-1 ingested at several timepoints 
throughout the day (0.8 – 1.6 g every 3 – 4 h) to avoid acute side-effects. Although the 
current data support the efficacy of β-alanine supplementation during certain types of 
exercise, the exact mechanisms by which increased carnosine contributes to improved 
exercise outcomes remains to be experimentally demonstrated. Further studies should aim to 
determine the exact contribution of carnosine to buffering capacity and the changes therein 
following dietary supplementation of β-alanine. Additionally, it would be of interest to 
determine the greatest exercise gains due to increased muscle carnosine concentration using 
more prolonged supplementation protocols, and whether gains directly mirror changes in 
intracellular carnosine. The current meta-analysis provides support to design the most 
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appropriate protocols to determine changes in muscle carnosine concentration with β-alanine 
(i.e., exercise capacity test of 0.5 to 10 min). 
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Table 1. All studies included in the meta-analysis.  
Authors & Location Participants Supplementation protocol Total dosage (g) Exercise protocol 
Baguet et al. [7] 
Belgium 
Elite male rowers 
PL = 9; BA = 8 
5.0 g
.
day
-1
 for 49 days 245 2000 m rowing ergometry 
     
Bellinger et al. [13] 
Australia 
Trained male cyclists 
PL = 7; BA = 7 
65 mg∙kg-1BM·day-1 for 4 weeks ~129.4 4 min maximal cycle bout 
     
Bellinger and Minhan [53] 
Australia 
Trained male cyclists 
PL = 7; BA = 7 
6.4 g
.
day
-1
 for 4 weeks 179.2 1 km cycling TT 
4 km cycling TT 
10 km cycling TT 
     
Carpentier et al. [54] 
Belgium 
Physically active males and females 
PL = 13; BA = 14 
5.6 g
.
day
-1
 for 8 weeks 313.6 Squat jump 
CMJ 
45 CMJ Fatigue test 
     
Chung et al. [55] 
Australia 
Elite/sub-elite male/female 
swimmers 
PL = /; BA = / 
4.8 g
.
day
-1
 for 4 weeks followed by 
3.2 g
.
day
-1
 for 6 weeks 
268.8 50 – 400 m swimming: 
Training performance 
Competition performance 
     
Chung et al. [42] 
Belgium/Australia 
Trained male cyclists 
PL = 13; BA = 14 
6.4 g
.
day
-1
 for 6 weeks 268.8 1 h cycling TT 
     
Cochran et al. [56]  
Canada 
Healthy young males 
PL = 12; BA = 12 
3.2 g
.
day
-1
 for 6 weeks 134.4 Incremental cycle test 
250 kJ cycling TT 
Repeated sprint cycle test 
     
Del Favero et al. [46] 
Brazil 
Elderly males and females 
PL = 6; BA = 12 
3.2 g
.
day
-1
 for 12 weeks 268.8 Constant load submaximal test 
Incremental treadmill test 
     
Derave et al. [5] 
Belgium 
Sprint trained competitive athletes 
PL = 7; BA = 8 
2.4 g
.
day
-1
 for 4 days, 3.6 g
.
day
-1
  for 
4 days, 4.8 g
.
day
-1
 up to 5 weeks 
153.6 400 m sprint 
Isometric endurance 
Maximal isokinetic knee extensions 
     
Ghiasvand et al. [57] 
Iran 
Recreational males 
PL = 19; BA = 20 
2.0 g
.
day
-1
 for 42 days 84 Graded exercise test 
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Glenn et al. [58] 
USA 
Female masters athletes 
PL = 11; BA = 11 
3.2 g
.
day
-1
 for 4 weeks 89.6 Lower body ISO strength 
Hand grip strength 
     
Gross et al. [9] 
Switzerland 
Recreational males 
PL = 9; BA = 9 
3.2 g
.
day
-1
 for 38 days 121.6 Maximal incremental cycle 
     
Gross et al. [25] 
Switzerland 
Elite male alpine skiers 
PL = 4; BA = 5 
4.8 g∙day-1 for 5 weeks 168 Counter movement jump 
90 s box jump test 
     
Hill et al. [4] 
UK 
Recreational males 
PL = 8; BA = 7 
4.0 g
.
day
-1
 in week 1 rising to 6.4 
g
.
day
-1
 by week 4 till week 10 
414.4 Cycling capacity test at 110% of 
PowerMax 
     
Hobson et al. [40] 
UK 
Trained male rowers 
PL = 10; BA = 10 
6.4 g
.
day
-1
 for 28 days 179.2 - 192 2000 m rowing ergometry 
     
Hoffman et al. [59] 
USA 
Elite male soldiers 
PL = 9; BA = 9 
6.0 g
.
day
-1
 for 4 weeks 168 4 km run 
5 countermovement jumps 
120 m sprint 
     
Hoffman et al. [60] 
USA 
Elite male soldiers 
PL = 9; BA = 9 
6.0 g
.
day
-1
 for 30 days 180 2.5 km run 
1-min sprint 
50 m casualty carry 
Repeated 30 m sprints 
     
Howe et al. [61] 
Australia 
Highly trained male cyclists 
PL = 8; BA = 8 
65 mg∙kg-1BM·day-1  for 4 weeks 127.4 4 min maximal cycle bout 
     
Jagim et al. [62] 
USA 
Anaerobically trained athletes 
PL = 11; BA = 10 
4.0 g
.
day
-1
 for 1 week followed by 6.0 
g
.
day
-1
 for 4 weeks  
196 Run to exhaustion at 115% VO2max 
Run to exhaustion at 140% VO2max 
     
James et al. [41] 
UK 
Trained male cyclists 
PL = 9; BA = 10 
6.4 g
.
day
-1
 for 4 weeks 179.2 20 km cycling TT 
     
Jordan et al. [63] 
USA 
Recreational males 
PL = 9; BA = 8 
6.0 g
.
day
-1
 for 4 weeks 168 Incremental treadmill run to 
exhaustion 
     
Okudan et al. [64] 
Turkey 
Untrained healthy males 
PL = 11; BA = 11 
3.2 g
.
day
-1
 for 22 days and 6.4 g
.
day
-1
 
for 6 days 
108.8 3 x 30 s Wingates 
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Painelli et al. [47] 
Brazil 
Male and female swimmers  
PL = 7; BA = 7 
3.2 g
.
day
-1
 for 1 week and 6.4 g
.
day
-1
 
for 3 weeks 
156.8 100 m swimming  
200 m swimming 
     
Painelli et al. [43] 
Brazil 
Trained male cyclists and 
recreational males 
PL = 19; BA = 20 
6.4 g
.
day
-1
 for 4 weeks 179.2 4 x 30 s cycle Wingates 
     
Sale et al. [18] 
UK 
Recreational males 
PL = 10; BA = 10 
6.4 g
.
day
-1
 for 4 weeks 179.2 Cycling capacity test at 110% of 
PowerMax 
     
Sale et al. [65] 
UK 
Recreational males 
PL = 6; BA = 7 
6.4 g
.
day
-1
 for 4 weeks 179.2 IKET 
     
Saunders et al. [66] 
UK 
Elite/non-elite male games players 
PL = 18; BA = 18 
6.4 g
.
day
-1
 for 4 weeks 179.2 Loughborough Intermittent Shuttle 
Test 
     
Saunders et al. [26] 
UK 
Amateur male footballers 
PL = 8; BA = 9 
3.2 g
.
day
-1
 for 12 weeks 268.8 YoYo Intermittent Recovery Test 
Level 2 
     
Saunders et al. [67] 
UK 
16 recreational males 
PL =  8; BA = 8 
6.4 g
.
day
-1
 for 4 weeks followed by 
3.2 g
.
day
-1
 for 1 week 
179.2 – 201.6 3 sets of 5 x 6 s repeated sprints 
     
Smith et al. [68]  
USA 
Recreational males 
PL = 18; BA = 18 
6.0 g
.
day
-1
 for 3 weeks followed by 
3.0 g
.
day
-1
 for 3 weeks 
189 Cycle capacity at 110% VO2max 
     
Smith et al. [69] 
USA 
Recreational women 
PL = 11; BA = 13 
4.8 g
.
day
-1
 for 4 weeks 134.4 Graded exercise test 
 
     
Smith-Ryan et al. [70] 
USA 
Recreational males 
PL = 24; BA = 26 
4.8 g
.
day
-1
 for 4 weeks 134.4 Run to exhaustion at 90% PV 
Run to exhaustion at 100% PV  
Run to exhaustion at 110% PV  
     
Smith-Ryan et al. [71] 
USA 
Recreational males and females 
PL = 15; BA = 15 
6.4 g
.
day
-1
 for 4 weeks 179.2 Graded exercise test 
 
     
Stout et al. [72] 
USA 
Males 
PL = 13; BA = 12 
6.4 g∙d-1 for 6 days, then 
3.2 g∙d-1  for 22 days 
108.8 Incremental cycle to exhaustion 
     
Stout et al. [73] Females 3.2 g∙d-1 for 7 days, then 156.8 Incremental cycle to exhaustion 
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USA PL = 11; BA = 11 6.4 g∙d-1 for 21 days 
     
Stout et al. [27] 
USA 
Elderly males and females 
PL = 14; BA = 12 
2.4 g∙d-1  for 90 days 216 Discontinuous incremental exercise 
protocol 
     
Tobias et al. [48] 
Brazil 
Martial arts male athletes 
PL = 9; BA = 10 
6.4 g
.
day
-1
 for 4 weeks 179.2 4 x 30 s upper body Wingates 
     
van Thienen et al. [74] 
Belgium 
Well-trained male cyclists 
PL = 8; BA = 9 
2 g
.
day
-1
 for 2 weeks, 3 g
.
day
-1
  for 2 
weeks, then 4 g
.
day
-1
  for 4 weeks 
182 Incremental cycle to exhaustion 
10 minute cycling TT 
30 s cycle sprint 
     
Walter et al. [75] 
USA 
Recreational females 
PL = 19; BA = 14 
6.0 g
.
day
-1
 for 3 weeks followed by 
3.0 g
.
day
-1
 for 3 weeks 
189 Graded exercise test 
 
     
Zoeller et al. [76] 
USA 
Healthy males 
PL = 13; BA = 12 
6.4 g
.
day
-1
 for 6 days followed by 3.2 
g
.
day
-1
 for 22 days 
108.8 Incremental cycle to exhaustion 
TT = Time trial; CMJ = Countermovement jump; ISO = Isokinetic strength; IKET = Isometric knee extension test at 45% of maximum 
voluntary contraction; PV = Peak velocity;  
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Table 2. Categorisation of studies for sub-analyses. 
Authors Exercise protocol [duration 1] [duration 2] [exercise type] [training status] [exercise mode] [intermittent] [study length] 
[total 
dose] 
  
1 = 0-1 min  
2 = 1-4 min 
3 = 4 min+ 
1 = 0-0.5 min 
2 = 0.5-10 min 
3 = 10 min+ 
1 = Capacity 
2 = Performance 
1 = Trained 
2 = Non-trained 
1 = Isolated limb 
2 = Whole body 
1 = Intermittent 
2 = Continuous 
(days) (g) 
       
 
  
Baguet et al. [7] 2000 m rowing 3 2 2 1 2 2 49 245 
Bellinger et al. [13] 4 min maximal cycle 2 2 2 1 1 2 28 129.4 
Bellinger and Minhan [53] 
1 km cycling TT 2 2 2 1 1 2 28 179.2 
4 km cycling TT 3 2 2 1 1 2 28 179.2 
10 km cycling TT 3 3 2 1 1 2 28 179.2 
Supramaximal cycle 2 2 1 1 1 2 28 179.2 
          
Carpentier et al. [54] 
Squat jump 1 1 1 2 1 2 56 313.6 
CMJ 1 1 1 2 1 2 56 313.6 
45 CMJ Fatigue test 2 2 2 2 1 2 56 313.6 
          
Chung et al. [55] 
Swimming Training 2 2 2 1 2 2 70 268.8 
Swimming Competition 2 2 2 1 2 2 70 268.8 
Chung et al. [42] 1 h cycling time trial 3 3 2 1 1 2 42 268.8 
Cochran et al. [56] 
 
Incremental cycle 3 3 1 2 1 2 42 134.4 
250 kJ cycle TT 3 3 2 2 1 2 42 134.4 
Repeated cycle sprints 2 2 2 2 1 1 42 134.4 
          
Del Favero et al. [46] 
Incremental treadmill test  3 3 1 2 2 2 84 268.8 
Treadmill test 3 2 1 2 2 2 84 268.8 
          
Derave et al. [5] 
Isometric endurance 2 2 1 1 1 2 36 153.6 
400 m running 1 2 2 1 2 2 36 153.6 
Maximal isokinetic knee extensions 1 1 1 1 1 2 36 153.6 
Ghiasvand et al. [57] Incremental cycle test 3 3 1 2 1 2 42 84 
Glenn et al. [58] 
Isokinetic strength – Flexion 2 2 2 1 1 2 28 89.6 
Isokinetic strength – Extension 2 2 2 1 1 2 28 89.6 
Hand grip test 1 1 1 1 1 2 28 89.6 
Gross et al. [9] Incremental cycle test  3 3 1 2 1 2 38 121.6 
Gross et al. [25] CMJ 1 1 1 1 1 2 35 168 
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90-s box jump test 2 2 2 1 1 2 35 168 
Hill et al. [4] CCT110% 2 2 1 2 1 2 70 414.4 
Hobson et al. [40] 2000 m rowing 3 2 2 1 2 2 35 192 
Hoffman et al. [59] 
4 km run 3 3 2 2 2 2 28 168 
CMJ (x5) 1 1 2 2 1 2 28 168 
120 m running sprint 1 1 2 2 2 2 28 168 
          
Hoffman et al. [60] 
2.5 km running sprint 3 3 2 2 2 2 30 180 
1 min running sprint 1 2 2 2 2 2 30 180 
Repeated 30 m sprints 1 1 2 2 2 1 30 180 
50 m casualty carry 1 1 2 2 2 2 30 180 
Howe et al. [61] 4 min maximal cycle 2 2 2 1 1 2 28 127.4 
Jagim et al. [62] 
Run at 115% VO2max 2 2 1 2 2 2 35 196 
Run at 140% VO2max 2 2 1 2 2 2 35 196 
James et al. [41] 20 km cycling TT 3 3 2 1 1 2 28 179.2 
Jordan et al. [63] Incremental treadmill test 3 3 1 2 2 2 28 168 
Okudan et al. [64] 3 bouts of 30 s cycling 2 2 2 2 1 1 28 108.8 
Painelli et al. [47] 
100 m swimming 2 2 2 1 2 2 28 156.8 
200 m swimming 2 2 2 1 2 2 28 156.8 
          
Painelli et al. [43] 4 bouts of 30 s cycling 
2 2 2 1 1 1 28 179.2 
2 2 2 2 1 1 28 179.2 
Sale et al. [18] CCT110% 2 2 1 2 1 2 28 179.2 
Sale et al. [65] Isometric endurance 2 2 1 2 1 2 28 179.2 
Saunders et al. [66] LIST 
2 2 2 1 2 1 28 179.2 
2 2 2 2 2 1 28 179.2 
Saunders et al. [26] YoYo IR2 3 2 1 1 2 1 84 268.8 
Saunders et al. [67] 5 x 6 s sprints 1 1 2 2 1 1 35 201.6 
Smith et al. [68] Cycle at 110% VO2max 2 2 1 2 1 2 42 189 
Smith et al. [69] Incremental treadmill test 3 2 1 2 2 2 28 134.4 
Smith-Ryan et al. [70] 
Run to exhaustion at 110% peak 
velocity 
2 2 1 2 2 2 28 134.4 
Run to exhaustion at 100% peak 
velocity 
2 2 1 2 2 2 28 134.4 
Run to exhaustion at 90% peak 
velocity 
2 2 1 2 2 2 28 134.4 
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Smith-Ryan et al. [71] Incremental cycle test 3 3 1 2 1 2 28 179.2 
Stout et al. [72] Incremental cycle test  3 3 1 2 1 2 28 108.8 
Stout et al. [73] Incremental cycle test  3 3 1 2 1 2 28 156.8 
Stout et al. [27] Incremental cycle test  3 3 1 2 1 2 90 216 
Tobias et al. [48] Upper-body Wingates 2 2 2 1 1 1 28 179.2 
van Thienen et al. [74] 
Incremental cycle test  3 3 1 1 1 2 56 182 
10 min cycling TT 3 2 2 1 1 2 56 182 
30 s cycle sprint 1 1 2 1 1 2 56 182 
Walter et al. [75] Incremental cycle test  3 3 1 2 1 2 42 189 
Zoeller et al. [76] Incremental cycle test 3 3 1 2 1 2 28 108.8 
TT = Time-trial; CMJ = Countermovement jump; VO2max = Maximal oxygen uptake; CCT110% = Cycling capacity test at 110% Powermax; LIST = Loughborough Intermittent 
Shuttle Test; YoYo IR2 = YoYo Intermittent Recovery Test Level 2 
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Table 3. Results of univariate meta-regressions. Parameter estimates and model outputs.  
Moderator 
Parameter 
Estimate 
Standard 
Error 
QMdf 
Between outcome variance  
(% of total variance) 
Between study variance  
(% of total variance) 
QEdf 
[duration 1] 
0 - 1 min 0.016 0.122 
14.13 0.144 (71.9%) 0.001          (0.5%) 240.867 1 - 4 min 0.210
*
 0.078 
4+ min 0.233
*
 0.089 
[duration 2] 
0 - 0.5 min 0.040 0.132 
13.33 0.146 (72.1%) 0.001          (0.5%) 242.267 0.5 - 10 min 0.224
*
 0.070 
10+ min 0.174 0.104 
[exercise type] 
Capacity 0.244
*
 0.076 
13.02 0.142 (71.2%) 0.003          (1.5%) 243.468 
Performance 0.126 0.084 
[training status] 
Trained 0.144 0.083 
12.12 0.145 (72.4%) 0          (0%) 244.468 
Non-Trained 0.207
*
 0.068 
[exercise mode] 
Isolated 0.185
*
 0.068 
11.72 0.146 (72.1%) 0          (0%) 244.868 
Whole body 0.176
*
 0.084 
[intermittent] 
Intermittent 0.284
*
 0.142 
12.42 0.145 (72.4%) 0          (0%) 243.768 
Continuous 0.165
*
 0.057 
[total dose] 
Intercept 0.060 0.171 
0.601 0.141 (69.4%) 0.006          (3.4%) 245.168 
Gradient 0.001 0.001 
[study length] 
Intercept -0.217 0.160 
8.061 0.108 (52.9%) 0.041          (20.1%) 240.868 
Gradient 0.011
*
 0.004 
* P ≤ 0.05. †. QMdf: Omnibus moderator test statistic. QEdf: Residual heterogeneity test statistic.  
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Figures 
Figure 1. Search strategy summery. 
 
Figure 2. Forest plot of the results of the random-effects meta-analysis shown as mean effect 
sizes with 95% CIs. Data are separated according to [duration 2]. The diamonds below each 
section represent the overall mean effect within the various sub-groups; the diamond below 
the graph represents the overall effect of BA vs. PL. 
 
Figure 3. Forest plot of the results of the random-effects meta-analysis for BASB vs. PL 
(Panel A) and BASB vs. BA (Panel B). Data points are shown as mean effect sizes with 95% 
CIs. The diamonds represent the overall mean effect within the sub-groups. 
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